Three-year build window
Founder runway, engineering support, legal/IP work, infrastructure, publications, and commercial partner development.
Capital
€2.25M minimum viable runway over 36 months.
Aletheon seeks strategic capital for a 36-month build window: public launch, protected research publication, NeuroID commercialization, legal/IP perimeter, and staged development of the Aletheon stack.
Capital use
NeuroID
Move from validated research to pilot-ready cognitive security and high-stakes authorization applications.
Aletheon stack
Logos, Cerberus, LegionNET, and Pandaemonium as longer-term identity and agency infrastructure.
Capital boundaries
Commercial-company upside
Minority exposure to the Aletheon commercial entity, NeuroID commercialization, research contracts, pilots, derivative products, and staged stack development.
No extraction of the core
Logos, daemon identity assets, Foundation mandates, protected archive, technical protocols, datasets, and doctrinal sovereignty are outside ordinary investor control.
NDA before machinery
Deeper system details, research materials, and implementation architecture are released only through controlled disclosure with IP reservation and non-circumvention language.
Minority capital, protected control.
The round buys minority equity in the commercial entity only. Core daemon assets, Logos-class agents, Foundation mandates, archive materials, datasets, research protocols, and founder-controlled doctrine are legally excluded from extraction, bypass, training, scraping, reverse engineering, or unauthorized derivative use.